Showing 2781-2790 of 10578 results for "".
Off-label Uses for Biologics
https://practicaldermatology.com/topics/psoriasis/off-label-uses-for-biologics/18964/Derm Insider Bonus Content: Host Neal Bhatia speaks with guests Alice Gottlieb, MD, Harold Farber, MD, and James Ulery, MD about various potential off-label uses for current and investigational systemic psoriasis therapies.The Importance of Planning
https://practicaldermatology.com/topics/practice-management/the-importance-of-planning/19082/Failing to plan is planning to fail, say Jay A. Shorr, BA, MBM-C, CAC I-V and Mara Shorr, BS, CAC II-V of The Best Medical Business Solutions. They tell aesthetic practices how to lay the foundation for success in minimally invasive procedures.Tips for Treating Children
https://practicaldermatology.com/conferences/noah-worcester/tips-for-treating-children/57066/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, discusses her two Alfred L. Weiner lectures on pediatric dermatology from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.The Noah Family
https://practicaldermatology.com/conferences/noah-worcester/the-noah-family/57061/Amy Spizuoco, DO, explains what makes the Noah Worcester Dermatological Society’s annual meetings special and what she took away from the 2026 Annual Meeting.Preparing for the Return of Measles
https://practicaldermatology.com/conferences/noah-worcester/preparing-for-the-return-of-measles/57064/Miriam Bettencourt, MD discusses her presentation, “Mission Impossible: The Spotted Reckoning,” from the Noah Worcester Dermatological Society’s 2026 Annual Meeting.Journal Club: Combination Therapy With Dupilumab and Upadacitinib
https://practicaldermatology.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-combination-therapy-with-dupilumab-and-upadacitinib/32408/Neal Bhatia, MD, FAAD, and Ted Lain, MD, MBA, FAAD, discuss the International Journal of Dermatology article “Combination Therapy With Upadacitinib and Dupilumab for Severe Atopic Dermatitis,” and their own experiences with similar treatment strategies.The Importance and Utility of GEP Testing
https://practicaldermatology.com/series/updates-in-skin-cancer/the-importance-and-utility-of-gep-testing/35597/Hadas Skupsky, MD, a board-certified dermatologist and dermatopathologist, discusses gene expression profiling technology and its importance in the diagnosis and prognostication of melanomas.Addressing Equity Gaps in Psoriasis Research
https://practicaldermatology.com/series/c-suite-chats/addressing-equity-gaps-in-psoriasis-research/33151/LaShell Robinson, Head, Global Feasibility and Trial Equity for Takeda, discusses the disproportionate underrepresentation of certain racial and ethnic groups in clinical trials, especially for psoriasis, and how Takeda is seeking to close those gaps in recent Phase 3 trials.'Combination Is Back,' Doctor Declares at Maui Derm
https://practicaldermatology.com/programs/practical-dermatology/combination-is-back-doctor-declares-at-maui-derm/32918/One of the most important studies of the past few years for dermatologists involved patients with ulcerative colitis, according to Arthur Kavanaugh, MD.Dr. Tsao, Dr. Friedlander Recap Biggest Developments for Maui Derm
https://practicaldermatology.com/conferences/maui-derm-hawaii-2025/dr-tsao-dr-friedlander-recap-biggest-developments-for-maui-derm/32913/The development of new therapeutics for dermatologic conditions in recent years has been so prolific that Hensin Tsao, MD, PhD, used a “Maui Journal of Medicine” theme for his conference-opening presentation at the Maui Derm Hawaii 2025 meeting in Maui, Hawaii.